Crestor RUSH (The efficacy of RosUvaStatin for Korean dyslipidemia patients with Hypertension ) - RUSH

Study identifier:NIS-CKR-CRE-2007/2

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

RUSH (Evaluating the efficacy of RosUvaStatin for Korean dyslipidemia patients with Hypertension in real world practice)

Medical condition

Dyslipidemia

Phase

-

Healthy volunteers

Yes

Study drug

-

Sex

All

Actual Enrollment

5000

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 May 2007
Primary Completion Date: 01 Nov 2007
Study Completion Date: 01 Nov 2007

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2010 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria